Effect of mitochondrial dysfunction on prognosis of patients undergoing video-assisted thoracoscopic surgery (VATS)

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200062303

Enrollment

Unknown

Registered

2022-08-01

Start date

2022-08-01

Completion date

Unknown

Last updated

2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mitochondrial dysfunction

Interventions

Severe complication group:None

Complication group:None

No complication group:None

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Age >= 18y, male or female; 2.Underwent VATS in our hospital; 3.Preoperative chest CT, lung function examination and blood test were performed, and relevant data were complete; 4.Patients fully understand the program and sign informed consent.

Exclusion criteria

Exclusion criteria: 1.Age <18y; 2.Patients with severe mental and cognitive impairment who were unable to comply with the examination required by the study; 3.Patients with limb hemiplegia or motor nerve injury caused by any reason; 4.Patients participate in other interventional clinical trials at the same time; 5.Complete medical records were not available.

Design outcomes

Primary

Measure	Time frame
Perioperative complication rate;Incidence of mitochondrial dysfunction;Metabolic changes in intercostal muscles;Overall survival rate;	—

Secondary

Measure	Time frame
Length of hospital stay after operation;Quality of life;	—

Countries

China

Contacts

Public ContactZhang Peng

446941219@qq.com+86 13636690390

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026